nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—ABCG2—Dactinomycin—testicular cancer	0.117	0.155	CbGbCtD
Prazosin—SLC22A2—Vinblastine—testicular cancer	0.0993	0.131	CbGbCtD
Prazosin—SLC22A2—Cisplatin—testicular cancer	0.0911	0.12	CbGbCtD
Prazosin—ABCG2—Carboplatin—testicular cancer	0.0787	0.104	CbGbCtD
Prazosin—ABCG2—Cisplatin—testicular cancer	0.0672	0.0888	CbGbCtD
Prazosin—ABCG2—Etoposide—testicular cancer	0.066	0.0873	CbGbCtD
Prazosin—ADRA1B—vas deferens—testicular cancer	0.05	0.52	CbGeAlD
Prazosin—ABCG2—Doxorubicin—testicular cancer	0.045	0.0595	CbGbCtD
Prazosin—ABCG2—Methotrexate—testicular cancer	0.0436	0.0577	CbGbCtD
Prazosin—ABCB1—Dactinomycin—testicular cancer	0.0422	0.0558	CbGbCtD
Prazosin—ABCB1—Vinblastine—testicular cancer	0.0264	0.0349	CbGbCtD
Prazosin—ABCB1—Cisplatin—testicular cancer	0.0242	0.032	CbGbCtD
Prazosin—ABCB1—Etoposide—testicular cancer	0.0238	0.0315	CbGbCtD
Prazosin—ABCB1—Doxorubicin—testicular cancer	0.0162	0.0215	CbGbCtD
Prazosin—ABCB1—Methotrexate—testicular cancer	0.0157	0.0208	CbGbCtD
Prazosin—MT3—testis—testicular cancer	0.00487	0.0507	CbGeAlD
Prazosin—KCNH7—testis—testicular cancer	0.00487	0.0507	CbGeAlD
Prazosin—MT3—lymph node—testicular cancer	0.00353	0.0368	CbGeAlD
Prazosin—SLC22A3—embryo—testicular cancer	0.00283	0.0295	CbGeAlD
Prazosin—SLC22A3—seminal vesicle—testicular cancer	0.00266	0.0277	CbGeAlD
Prazosin—KCNH2—seminal vesicle—testicular cancer	0.00205	0.0213	CbGeAlD
Prazosin—SLC22A3—gonad—testicular cancer	0.00192	0.02	CbGeAlD
Prazosin—ABCG2—seminal vesicle—testicular cancer	0.00182	0.019	CbGeAlD
Prazosin—ADRA2A—seminal vesicle—testicular cancer	0.00161	0.0168	CbGeAlD
Prazosin—SLC22A3—female gonad—testicular cancer	0.00156	0.0163	CbGeAlD
Prazosin—SLC22A3—testis—testicular cancer	0.00139	0.0144	CbGeAlD
Prazosin—KCNH2—female gonad—testicular cancer	0.0012	0.0125	CbGeAlD
Prazosin—ADRA2A—gonad—testicular cancer	0.00116	0.0121	CbGeAlD
Prazosin—ORM1—lymph node—testicular cancer	0.00115	0.0119	CbGeAlD
Prazosin—ABCG2—female gonad—testicular cancer	0.00107	0.0111	CbGeAlD
Prazosin—KCNH2—testis—testicular cancer	0.00107	0.0111	CbGeAlD
Prazosin—CYP1A1—female gonad—testicular cancer	0.00102	0.0106	CbGeAlD
Prazosin—SLC22A3—lymph node—testicular cancer	0.001	0.0105	CbGeAlD
Prazosin—ABCB1—embryo—testicular cancer	0.000956	0.00996	CbGeAlD
Prazosin—ABCG2—testis—testicular cancer	0.000949	0.00988	CbGeAlD
Prazosin—ADRA2A—female gonad—testicular cancer	0.000947	0.00986	CbGeAlD
Prazosin—ABCB1—seminal vesicle—testicular cancer	0.000898	0.00935	CbGeAlD
Prazosin—ADRA2A—testis—testicular cancer	0.00084	0.00874	CbGeAlD
Prazosin—KCNH2—lymph node—testicular cancer	0.000773	0.00805	CbGeAlD
Prazosin—Vision blurred—Ifosfamide—testicular cancer	0.000702	0.00477	CcSEcCtD
Prazosin—Feeling abnormal—Vinblastine—testicular cancer	0.000694	0.00471	CcSEcCtD
Prazosin—Ill-defined disorder—Ifosfamide—testicular cancer	0.000691	0.00469	CcSEcCtD
Prazosin—Tinnitus—Cisplatin—testicular cancer	0.000688	0.00467	CcSEcCtD
Prazosin—ABCG2—lymph node—testicular cancer	0.000688	0.00716	CbGeAlD
Prazosin—Flushing—Cisplatin—testicular cancer	0.000685	0.00465	CcSEcCtD
Prazosin—Discomfort—Dactinomycin—testicular cancer	0.000684	0.00464	CcSEcCtD
Prazosin—Hypersensitivity—Chlorambucil—testicular cancer	0.000677	0.0046	CcSEcCtD
Prazosin—Malaise—Ifosfamide—testicular cancer	0.000672	0.00456	CcSEcCtD
Prazosin—Vertigo—Ifosfamide—testicular cancer	0.00067	0.00455	CcSEcCtD
Prazosin—Oedema—Dactinomycin—testicular cancer	0.000664	0.00451	CcSEcCtD
Prazosin—Asthenia—Chlorambucil—testicular cancer	0.00066	0.00448	CcSEcCtD
Prazosin—Palpitations—Ifosfamide—testicular cancer	0.000659	0.00447	CcSEcCtD
Prazosin—CYP1A1—lymph node—testicular cancer	0.000653	0.0068	CbGeAlD
Prazosin—Alopecia—Cisplatin—testicular cancer	0.000652	0.00443	CcSEcCtD
Prazosin—Pruritus—Chlorambucil—testicular cancer	0.000651	0.00442	CcSEcCtD
Prazosin—ABCB1—gonad—testicular cancer	0.000649	0.00676	CbGeAlD
Prazosin—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000648	0.0044	CcSEcCtD
Prazosin—Paraesthesia—Bleomycin—testicular cancer	0.000639	0.00434	CcSEcCtD
Prazosin—Dyspnoea—Bleomycin—testicular cancer	0.000635	0.00431	CcSEcCtD
Prazosin—Arthralgia—Ifosfamide—testicular cancer	0.000634	0.00431	CcSEcCtD
Prazosin—Diarrhoea—Chlorambucil—testicular cancer	0.000629	0.00427	CcSEcCtD
Prazosin—Flushing—Etoposide—testicular cancer	0.000628	0.00426	CcSEcCtD
Prazosin—Discomfort—Ifosfamide—testicular cancer	0.000627	0.00426	CcSEcCtD
Prazosin—Hypersensitivity—Vinblastine—testicular cancer	0.000621	0.00422	CcSEcCtD
Prazosin—ADRA2A—lymph node—testicular cancer	0.000609	0.00634	CbGeAlD
Prazosin—Pain—Bleomycin—testicular cancer	0.000609	0.00413	CcSEcCtD
Prazosin—Oedema—Ifosfamide—testicular cancer	0.000608	0.00413	CcSEcCtD
Prazosin—Eye pain—Epirubicin—testicular cancer	0.000607	0.00412	CcSEcCtD
Prazosin—Vision blurred—Cisplatin—testicular cancer	0.000606	0.00411	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000605	0.00411	CcSEcCtD
Prazosin—Asthenia—Vinblastine—testicular cancer	0.000605	0.0041	CcSEcCtD
Prazosin—Alopecia—Etoposide—testicular cancer	0.000598	0.00406	CcSEcCtD
Prazosin—Ill-defined disorder—Cisplatin—testicular cancer	0.000596	0.00405	CcSEcCtD
Prazosin—Hyperhidrosis—Ifosfamide—testicular cancer	0.000588	0.00399	CcSEcCtD
Prazosin—Feeling abnormal—Bleomycin—testicular cancer	0.000586	0.00398	CcSEcCtD
Prazosin—Vomiting—Chlorambucil—testicular cancer	0.000585	0.00397	CcSEcCtD
Prazosin—Malaise—Cisplatin—testicular cancer	0.000579	0.00393	CcSEcCtD
Prazosin—Diarrhoea—Vinblastine—testicular cancer	0.000577	0.00391	CcSEcCtD
Prazosin—Fatigue—Dactinomycin—testicular cancer	0.000572	0.00389	CcSEcCtD
Prazosin—Pain—Dactinomycin—testicular cancer	0.000568	0.00385	CcSEcCtD
Prazosin—Urticaria—Bleomycin—testicular cancer	0.000565	0.00384	CcSEcCtD
Prazosin—Body temperature increased—Bleomycin—testicular cancer	0.000563	0.00382	CcSEcCtD
Prazosin—Eye pain—Doxorubicin—testicular cancer	0.000562	0.00381	CcSEcCtD
Prazosin—Dizziness—Vinblastine—testicular cancer	0.000557	0.00378	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000554	0.00376	CcSEcCtD
Prazosin—Feeling abnormal—Dactinomycin—testicular cancer	0.000547	0.00371	CcSEcCtD
Prazosin—Nausea—Chlorambucil—testicular cancer	0.000546	0.00371	CcSEcCtD
Prazosin—Paraesthesia—Ifosfamide—testicular cancer	0.000546	0.00371	CcSEcCtD
Prazosin—Ill-defined disorder—Etoposide—testicular cancer	0.000546	0.00371	CcSEcCtD
Prazosin—Dyspnoea—Ifosfamide—testicular cancer	0.000542	0.00368	CcSEcCtD
Prazosin—Somnolence—Ifosfamide—testicular cancer	0.000541	0.00367	CcSEcCtD
Prazosin—Discomfort—Cisplatin—testicular cancer	0.00054	0.00367	CcSEcCtD
Prazosin—Vomiting—Vinblastine—testicular cancer	0.000536	0.00364	CcSEcCtD
Prazosin—Malaise—Etoposide—testicular cancer	0.000531	0.0036	CcSEcCtD
Prazosin—Vertigo—Etoposide—testicular cancer	0.000529	0.00359	CcSEcCtD
Prazosin—Headache—Vinblastine—testicular cancer	0.000528	0.00358	CcSEcCtD
Prazosin—ABCB1—female gonad—testicular cancer	0.000528	0.00549	CbGeAlD
Prazosin—Body temperature increased—Dactinomycin—testicular cancer	0.000525	0.00356	CcSEcCtD
Prazosin—Fatigue—Ifosfamide—testicular cancer	0.000524	0.00356	CcSEcCtD
Prazosin—Oedema—Cisplatin—testicular cancer	0.000524	0.00356	CcSEcCtD
Prazosin—Hypersensitivity—Bleomycin—testicular cancer	0.000524	0.00356	CcSEcCtD
Prazosin—Pain—Ifosfamide—testicular cancer	0.00052	0.00353	CcSEcCtD
Prazosin—Constipation—Ifosfamide—testicular cancer	0.00052	0.00353	CcSEcCtD
Prazosin—Loss of consciousness—Etoposide—testicular cancer	0.000517	0.00351	CcSEcCtD
Prazosin—Tachycardia—Cisplatin—testicular cancer	0.000512	0.00347	CcSEcCtD
Prazosin—Asthenia—Bleomycin—testicular cancer	0.000511	0.00347	CcSEcCtD
Prazosin—Hyperhidrosis—Cisplatin—testicular cancer	0.000507	0.00344	CcSEcCtD
Prazosin—Pruritus—Bleomycin—testicular cancer	0.000504	0.00342	CcSEcCtD
Prazosin—Feeling abnormal—Ifosfamide—testicular cancer	0.000501	0.0034	CcSEcCtD
Prazosin—Nausea—Vinblastine—testicular cancer	0.000501	0.0034	CcSEcCtD
Prazosin—Orthostatic hypotension—Epirubicin—testicular cancer	0.0005	0.0034	CcSEcCtD
Prazosin—Pancreatitis—Methotrexate—testicular cancer	0.000496	0.00337	CcSEcCtD
Prazosin—Discomfort—Etoposide—testicular cancer	0.000495	0.00336	CcSEcCtD
Prazosin—Hypersensitivity—Dactinomycin—testicular cancer	0.000489	0.00332	CcSEcCtD
Prazosin—Abdominal discomfort—Methotrexate—testicular cancer	0.000485	0.00329	CcSEcCtD
Prazosin—Urticaria—Ifosfamide—testicular cancer	0.000483	0.00328	CcSEcCtD
Prazosin—Body temperature increased—Ifosfamide—testicular cancer	0.000481	0.00326	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000478	0.00324	CcSEcCtD
Prazosin—Asthenia—Dactinomycin—testicular cancer	0.000476	0.00323	CcSEcCtD
Prazosin—Paraesthesia—Cisplatin—testicular cancer	0.000471	0.0032	CcSEcCtD
Prazosin—Tachycardia—Etoposide—testicular cancer	0.000469	0.00318	CcSEcCtD
Prazosin—ABCB1—testis—testicular cancer	0.000468	0.00487	CbGeAlD
Prazosin—Dyspnoea—Cisplatin—testicular cancer	0.000467	0.00317	CcSEcCtD
Prazosin—Erectile dysfunction—Methotrexate—testicular cancer	0.000466	0.00316	CcSEcCtD
Prazosin—Hyperhidrosis—Etoposide—testicular cancer	0.000464	0.00315	CcSEcCtD
Prazosin—Pancreatitis—Epirubicin—testicular cancer	0.000464	0.00315	CcSEcCtD
Prazosin—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000463	0.00314	CcSEcCtD
Prazosin—Angina pectoris—Epirubicin—testicular cancer	0.000461	0.00313	CcSEcCtD
Prazosin—Diarrhoea—Dactinomycin—testicular cancer	0.000454	0.00308	CcSEcCtD
Prazosin—Vomiting—Bleomycin—testicular cancer	0.000453	0.00307	CcSEcCtD
Prazosin—Drowsiness—Methotrexate—testicular cancer	0.000451	0.00306	CcSEcCtD
Prazosin—Rash—Bleomycin—testicular cancer	0.000449	0.00305	CcSEcCtD
Prazosin—Pain—Cisplatin—testicular cancer	0.000448	0.00304	CcSEcCtD
Prazosin—Dermatitis—Bleomycin—testicular cancer	0.000448	0.00304	CcSEcCtD
Prazosin—Hypersensitivity—Ifosfamide—testicular cancer	0.000448	0.00304	CcSEcCtD
Prazosin—Pollakiuria—Epirubicin—testicular cancer	0.000437	0.00297	CcSEcCtD
Prazosin—Asthenia—Ifosfamide—testicular cancer	0.000436	0.00296	CcSEcCtD
Prazosin—Feeling abnormal—Cisplatin—testicular cancer	0.000432	0.00293	CcSEcCtD
Prazosin—Paraesthesia—Etoposide—testicular cancer	0.000431	0.00293	CcSEcCtD
Prazosin—Pruritus—Ifosfamide—testicular cancer	0.00043	0.00292	CcSEcCtD
Prazosin—Pancreatitis—Doxorubicin—testicular cancer	0.00043	0.00292	CcSEcCtD
Prazosin—Dyspnoea—Etoposide—testicular cancer	0.000428	0.00291	CcSEcCtD
Prazosin—Somnolence—Etoposide—testicular cancer	0.000427	0.0029	CcSEcCtD
Prazosin—Angina pectoris—Doxorubicin—testicular cancer	0.000427	0.0029	CcSEcCtD
Prazosin—Epistaxis—Methotrexate—testicular cancer	0.000426	0.00289	CcSEcCtD
Prazosin—Nausea—Bleomycin—testicular cancer	0.000423	0.00287	CcSEcCtD
Prazosin—Drowsiness—Epirubicin—testicular cancer	0.000422	0.00287	CcSEcCtD
Prazosin—Vomiting—Dactinomycin—testicular cancer	0.000422	0.00287	CcSEcCtD
Prazosin—Rash—Dactinomycin—testicular cancer	0.000419	0.00284	CcSEcCtD
Prazosin—Diarrhoea—Ifosfamide—testicular cancer	0.000416	0.00283	CcSEcCtD
Prazosin—Body temperature increased—Cisplatin—testicular cancer	0.000415	0.00281	CcSEcCtD
Prazosin—Fatigue—Etoposide—testicular cancer	0.000414	0.00281	CcSEcCtD
Prazosin—Pain—Etoposide—testicular cancer	0.000411	0.00279	CcSEcCtD
Prazosin—Constipation—Etoposide—testicular cancer	0.000411	0.00279	CcSEcCtD
Prazosin—Pollakiuria—Doxorubicin—testicular cancer	0.000405	0.00275	CcSEcCtD
Prazosin—Dizziness—Ifosfamide—testicular cancer	0.000402	0.00273	CcSEcCtD
Prazosin—Epistaxis—Epirubicin—testicular cancer	0.000398	0.0027	CcSEcCtD
Prazosin—Feeling abnormal—Etoposide—testicular cancer	0.000396	0.00269	CcSEcCtD
Prazosin—Nausea—Dactinomycin—testicular cancer	0.000394	0.00268	CcSEcCtD
Prazosin—Drowsiness—Doxorubicin—testicular cancer	0.000391	0.00265	CcSEcCtD
Prazosin—Vomiting—Ifosfamide—testicular cancer	0.000387	0.00263	CcSEcCtD
Prazosin—Hypersensitivity—Cisplatin—testicular cancer	0.000386	0.00262	CcSEcCtD
Prazosin—Bradycardia—Epirubicin—testicular cancer	0.000386	0.00262	CcSEcCtD
Prazosin—Rash—Ifosfamide—testicular cancer	0.000384	0.0026	CcSEcCtD
Prazosin—Dermatitis—Ifosfamide—testicular cancer	0.000383	0.0026	CcSEcCtD
Prazosin—Urticaria—Etoposide—testicular cancer	0.000382	0.00259	CcSEcCtD
Prazosin—Body temperature increased—Etoposide—testicular cancer	0.00038	0.00258	CcSEcCtD
Prazosin—Tinnitus—Methotrexate—testicular cancer	0.000378	0.00256	CcSEcCtD
Prazosin—Asthenia—Cisplatin—testicular cancer	0.000376	0.00255	CcSEcCtD
Prazosin—Epistaxis—Doxorubicin—testicular cancer	0.000368	0.0025	CcSEcCtD
Prazosin—Nausea—Ifosfamide—testicular cancer	0.000361	0.00245	CcSEcCtD
Prazosin—Diarrhoea—Cisplatin—testicular cancer	0.000359	0.00244	CcSEcCtD
Prazosin—Alopecia—Methotrexate—testicular cancer	0.000358	0.00243	CcSEcCtD
Prazosin—Bradycardia—Doxorubicin—testicular cancer	0.000357	0.00242	CcSEcCtD
Prazosin—Hypersensitivity—Etoposide—testicular cancer	0.000354	0.0024	CcSEcCtD
Prazosin—Tinnitus—Epirubicin—testicular cancer	0.000353	0.0024	CcSEcCtD
Prazosin—Flushing—Epirubicin—testicular cancer	0.000352	0.00239	CcSEcCtD
Prazosin—Asthenia—Etoposide—testicular cancer	0.000345	0.00234	CcSEcCtD
Prazosin—Pruritus—Etoposide—testicular cancer	0.00034	0.00231	CcSEcCtD
Prazosin—ABCB1—lymph node—testicular cancer	0.000339	0.00353	CbGeAlD
Prazosin—Alopecia—Epirubicin—testicular cancer	0.000335	0.00227	CcSEcCtD
Prazosin—Vomiting—Cisplatin—testicular cancer	0.000333	0.00226	CcSEcCtD
Prazosin—Vision blurred—Methotrexate—testicular cancer	0.000332	0.00226	CcSEcCtD
Prazosin—Rash—Cisplatin—testicular cancer	0.000331	0.00224	CcSEcCtD
Prazosin—Dermatitis—Cisplatin—testicular cancer	0.00033	0.00224	CcSEcCtD
Prazosin—Diarrhoea—Etoposide—testicular cancer	0.000329	0.00223	CcSEcCtD
Prazosin—Ill-defined disorder—Methotrexate—testicular cancer	0.000327	0.00222	CcSEcCtD
Prazosin—Tinnitus—Doxorubicin—testicular cancer	0.000327	0.00222	CcSEcCtD
Prazosin—Flushing—Doxorubicin—testicular cancer	0.000325	0.00221	CcSEcCtD
Prazosin—Tension—Epirubicin—testicular cancer	0.000324	0.0022	CcSEcCtD
Prazosin—Nervousness—Epirubicin—testicular cancer	0.00032	0.00218	CcSEcCtD
Prazosin—Malaise—Methotrexate—testicular cancer	0.000318	0.00216	CcSEcCtD
Prazosin—Dizziness—Etoposide—testicular cancer	0.000318	0.00216	CcSEcCtD
Prazosin—Vertigo—Methotrexate—testicular cancer	0.000317	0.00215	CcSEcCtD
Prazosin—Nausea—Cisplatin—testicular cancer	0.000311	0.00211	CcSEcCtD
Prazosin—Vision blurred—Epirubicin—testicular cancer	0.000311	0.00211	CcSEcCtD
Prazosin—Alopecia—Doxorubicin—testicular cancer	0.00031	0.0021	CcSEcCtD
Prazosin—Ill-defined disorder—Epirubicin—testicular cancer	0.000306	0.00208	CcSEcCtD
Prazosin—Vomiting—Etoposide—testicular cancer	0.000305	0.00207	CcSEcCtD
Prazosin—Rash—Etoposide—testicular cancer	0.000303	0.00206	CcSEcCtD
Prazosin—Dermatitis—Etoposide—testicular cancer	0.000303	0.00205	CcSEcCtD
Prazosin—Headache—Etoposide—testicular cancer	0.000301	0.00204	CcSEcCtD
Prazosin—Arthralgia—Methotrexate—testicular cancer	0.0003	0.00204	CcSEcCtD
Prazosin—Tension—Doxorubicin—testicular cancer	0.0003	0.00203	CcSEcCtD
Prazosin—Malaise—Epirubicin—testicular cancer	0.000298	0.00202	CcSEcCtD
Prazosin—Discomfort—Methotrexate—testicular cancer	0.000297	0.00201	CcSEcCtD
Prazosin—Nervousness—Doxorubicin—testicular cancer	0.000297	0.00201	CcSEcCtD
Prazosin—Vertigo—Epirubicin—testicular cancer	0.000296	0.00201	CcSEcCtD
Prazosin—Syncope—Epirubicin—testicular cancer	0.000296	0.00201	CcSEcCtD
Prazosin—Palpitations—Epirubicin—testicular cancer	0.000292	0.00198	CcSEcCtD
Prazosin—Loss of consciousness—Epirubicin—testicular cancer	0.00029	0.00197	CcSEcCtD
Prazosin—Vision blurred—Doxorubicin—testicular cancer	0.000288	0.00195	CcSEcCtD
Prazosin—Nausea—Etoposide—testicular cancer	0.000285	0.00194	CcSEcCtD
Prazosin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000283	0.00192	CcSEcCtD
Prazosin—Arthralgia—Epirubicin—testicular cancer	0.000281	0.00191	CcSEcCtD
Prazosin—Hyperhidrosis—Methotrexate—testicular cancer	0.000278	0.00189	CcSEcCtD
Prazosin—Discomfort—Epirubicin—testicular cancer	0.000278	0.00188	CcSEcCtD
Prazosin—Malaise—Doxorubicin—testicular cancer	0.000275	0.00187	CcSEcCtD
Prazosin—Dry mouth—Epirubicin—testicular cancer	0.000275	0.00187	CcSEcCtD
Prazosin—Vertigo—Doxorubicin—testicular cancer	0.000274	0.00186	CcSEcCtD
Prazosin—Syncope—Doxorubicin—testicular cancer	0.000274	0.00186	CcSEcCtD
Prazosin—Palpitations—Doxorubicin—testicular cancer	0.00027	0.00183	CcSEcCtD
Prazosin—Oedema—Epirubicin—testicular cancer	0.000269	0.00183	CcSEcCtD
Prazosin—Loss of consciousness—Doxorubicin—testicular cancer	0.000268	0.00182	CcSEcCtD
Prazosin—Shock—Epirubicin—testicular cancer	0.000265	0.0018	CcSEcCtD
Prazosin—Tachycardia—Epirubicin—testicular cancer	0.000263	0.00178	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000262	0.00178	CcSEcCtD
Prazosin—Hyperhidrosis—Epirubicin—testicular cancer	0.00026	0.00177	CcSEcCtD
Prazosin—Insomnia—Methotrexate—testicular cancer	0.00026	0.00177	CcSEcCtD
Prazosin—Arthralgia—Doxorubicin—testicular cancer	0.00026	0.00176	CcSEcCtD
Prazosin—Paraesthesia—Methotrexate—testicular cancer	0.000258	0.00175	CcSEcCtD
Prazosin—Discomfort—Doxorubicin—testicular cancer	0.000257	0.00174	CcSEcCtD
Prazosin—Dyspnoea—Methotrexate—testicular cancer	0.000257	0.00174	CcSEcCtD
Prazosin—Somnolence—Methotrexate—testicular cancer	0.000256	0.00174	CcSEcCtD
Prazosin—Dry mouth—Doxorubicin—testicular cancer	0.000254	0.00173	CcSEcCtD
Prazosin—Oedema—Doxorubicin—testicular cancer	0.000249	0.00169	CcSEcCtD
Prazosin—Fatigue—Methotrexate—testicular cancer	0.000248	0.00168	CcSEcCtD
Prazosin—Pain—Methotrexate—testicular cancer	0.000246	0.00167	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000245	0.00167	CcSEcCtD
Prazosin—Shock—Doxorubicin—testicular cancer	0.000245	0.00166	CcSEcCtD
Prazosin—Insomnia—Epirubicin—testicular cancer	0.000244	0.00165	CcSEcCtD
Prazosin—Tachycardia—Doxorubicin—testicular cancer	0.000243	0.00165	CcSEcCtD
Prazosin—Paraesthesia—Epirubicin—testicular cancer	0.000242	0.00164	CcSEcCtD
Prazosin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000241	0.00164	CcSEcCtD
Prazosin—Dyspnoea—Epirubicin—testicular cancer	0.00024	0.00163	CcSEcCtD
Prazosin—Somnolence—Epirubicin—testicular cancer	0.000239	0.00163	CcSEcCtD
Prazosin—Feeling abnormal—Methotrexate—testicular cancer	0.000237	0.00161	CcSEcCtD
Prazosin—Fatigue—Epirubicin—testicular cancer	0.000232	0.00158	CcSEcCtD
Prazosin—Pain—Epirubicin—testicular cancer	0.00023	0.00156	CcSEcCtD
Prazosin—Constipation—Epirubicin—testicular cancer	0.00023	0.00156	CcSEcCtD
Prazosin—Urticaria—Methotrexate—testicular cancer	0.000229	0.00155	CcSEcCtD
Prazosin—Body temperature increased—Methotrexate—testicular cancer	0.000227	0.00154	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000227	0.00154	CcSEcCtD
Prazosin—Insomnia—Doxorubicin—testicular cancer	0.000225	0.00153	CcSEcCtD
Prazosin—Paraesthesia—Doxorubicin—testicular cancer	0.000224	0.00152	CcSEcCtD
Prazosin—Dyspnoea—Doxorubicin—testicular cancer	0.000222	0.00151	CcSEcCtD
Prazosin—Feeling abnormal—Epirubicin—testicular cancer	0.000222	0.00151	CcSEcCtD
Prazosin—Somnolence—Doxorubicin—testicular cancer	0.000222	0.0015	CcSEcCtD
Prazosin—Fatigue—Doxorubicin—testicular cancer	0.000215	0.00146	CcSEcCtD
Prazosin—Urticaria—Epirubicin—testicular cancer	0.000214	0.00145	CcSEcCtD
Prazosin—Pain—Doxorubicin—testicular cancer	0.000213	0.00145	CcSEcCtD
Prazosin—Constipation—Doxorubicin—testicular cancer	0.000213	0.00145	CcSEcCtD
Prazosin—Body temperature increased—Epirubicin—testicular cancer	0.000213	0.00145	CcSEcCtD
Prazosin—Hypersensitivity—Methotrexate—testicular cancer	0.000212	0.00144	CcSEcCtD
Prazosin—Asthenia—Methotrexate—testicular cancer	0.000206	0.0014	CcSEcCtD
Prazosin—Feeling abnormal—Doxorubicin—testicular cancer	0.000205	0.00139	CcSEcCtD
Prazosin—Pruritus—Methotrexate—testicular cancer	0.000204	0.00138	CcSEcCtD
Prazosin—Hypersensitivity—Epirubicin—testicular cancer	0.000198	0.00135	CcSEcCtD
Prazosin—Urticaria—Doxorubicin—testicular cancer	0.000198	0.00134	CcSEcCtD
Prazosin—Body temperature increased—Doxorubicin—testicular cancer	0.000197	0.00134	CcSEcCtD
Prazosin—Diarrhoea—Methotrexate—testicular cancer	0.000197	0.00134	CcSEcCtD
Prazosin—Asthenia—Epirubicin—testicular cancer	0.000193	0.00131	CcSEcCtD
Prazosin—Pruritus—Epirubicin—testicular cancer	0.000191	0.00129	CcSEcCtD
Prazosin—Dizziness—Methotrexate—testicular cancer	0.00019	0.00129	CcSEcCtD
Prazosin—Diarrhoea—Epirubicin—testicular cancer	0.000184	0.00125	CcSEcCtD
Prazosin—Hypersensitivity—Doxorubicin—testicular cancer	0.000184	0.00125	CcSEcCtD
Prazosin—Vomiting—Methotrexate—testicular cancer	0.000183	0.00124	CcSEcCtD
Prazosin—Rash—Methotrexate—testicular cancer	0.000181	0.00123	CcSEcCtD
Prazosin—Dermatitis—Methotrexate—testicular cancer	0.000181	0.00123	CcSEcCtD
Prazosin—Headache—Methotrexate—testicular cancer	0.00018	0.00122	CcSEcCtD
Prazosin—Asthenia—Doxorubicin—testicular cancer	0.000179	0.00121	CcSEcCtD
Prazosin—Dizziness—Epirubicin—testicular cancer	0.000178	0.00121	CcSEcCtD
Prazosin—Pruritus—Doxorubicin—testicular cancer	0.000176	0.0012	CcSEcCtD
Prazosin—Vomiting—Epirubicin—testicular cancer	0.000171	0.00116	CcSEcCtD
Prazosin—Nausea—Methotrexate—testicular cancer	0.000171	0.00116	CcSEcCtD
Prazosin—Diarrhoea—Doxorubicin—testicular cancer	0.00017	0.00116	CcSEcCtD
Prazosin—Rash—Epirubicin—testicular cancer	0.00017	0.00115	CcSEcCtD
Prazosin—Dermatitis—Epirubicin—testicular cancer	0.00017	0.00115	CcSEcCtD
Prazosin—Headache—Epirubicin—testicular cancer	0.000169	0.00115	CcSEcCtD
Prazosin—Dizziness—Doxorubicin—testicular cancer	0.000165	0.00112	CcSEcCtD
Prazosin—Nausea—Epirubicin—testicular cancer	0.00016	0.00109	CcSEcCtD
Prazosin—Vomiting—Doxorubicin—testicular cancer	0.000158	0.00108	CcSEcCtD
Prazosin—Rash—Doxorubicin—testicular cancer	0.000157	0.00107	CcSEcCtD
Prazosin—Dermatitis—Doxorubicin—testicular cancer	0.000157	0.00107	CcSEcCtD
Prazosin—Headache—Doxorubicin—testicular cancer	0.000156	0.00106	CcSEcCtD
Prazosin—Nausea—Doxorubicin—testicular cancer	0.000148	0.001	CcSEcCtD
